Stage 4 Lung Cancer Survivor Summer Farmen Becomes VP, Co-Authors Study 6 Years Later
Updated
Updated · Business Insider · Jul 21
Stage 4 Lung Cancer Survivor Summer Farmen Becomes VP, Co-Authors Study 6 Years Later
1 articles · Updated · Business Insider · Jul 21
Summary
More than 6 years after a stage 4 lung cancer diagnosis, 50-year-old Summer Farmen has become vice president of nonprofit Alk Positive Inc. and co-authored a recent study in the journal Lung Cancer.
Her case involved ALK-positive lung cancer, a subtype driven by a gene mutation that can respond well to targeted therapy; doctors had drained 2 liters of fluid from her lungs before diagnosing it.
The study examined how patients and caregivers weigh treatment benefits against side effects, reflecting Farmen's push to give patients a stronger voice in increasingly personalized cancer care.
Farmen said support groups became a lifeline during treatment and later led her from a Zoom art therapy class into advocacy, education programs and research work.
She still undergoes scans every 3 months and says progression is a matter of when, not if, underscoring both the gains and ongoing burden of life-extending treatment.